JPRN-UMIN000031979
Completed
未知
Proactive management with topical corticosteroids ointment in pediatric atopic dermatitis : Superiority to rank-down therapy - Proactive management with topical corticosteroids ointment in pediatric atopic dermatitis : Superiority to rank-down therapy (Anticipate study)
Jichi Medical University School of Medicine0 sites90 target enrollmentMarch 29, 2018
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Jichi Medical University School of Medicine
- Enrollment
- 90
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients meeting any of the following criteria are not to be enrolled in the study. (1\) Patients with skin infections caused by bacteria, fungi, spirochetes or viruses and patients with ectoparasitic skin diseases (scabies, pubic lice, etc.). (2\)History of hypersensitivity to any components of the topical steroid and/or moisturizer to be used (3\) Patients with ulcers (except for Bechet's disease) and patients with deep burns or frostbite of second degree or higher. (4\) Patients complicated with an active infection in the area the study drug is to be applied. (5\) Patients complicated with Kaposi's varicelliform eruption, scabies, molluscum contagious, psoriasis, disorders (Netherton syndrome, etc.) presenting with ichthyosiform erythroderma, collagen disease (SLE and dermatomyositis), and skin disorder on the area study drug is to be applied to, which can affect evaluation. (6\) Patients who used the following drug within 28 days prior to Visit 1 (at the time of informed consent) \> Systemic adrenocortical steroid (oral, injectable, suppository, and inhaled) \> Topical steroid (strongest) \> Systemic immunosuppressant \> Live vaccine (7\) Patients who received phototherapy (UVB, Narrow\-band UVB, PUVA , etc.) within 28 days prior to Visit 1 (at the time of informed consent) (8\) Patients who participated in another clinical trial (including clinical trial of medical device) or clinical research involving intervention within 12 weeks prior to Visit 1 (at the time of informed consent) (9\) Patients determined by the investigator to be unsuitable for the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
Corticosteroid eye-drops for bacterial keratitisBacterial keratitisEye - Diseases / disorders of the eyeInfection - Other infectious diseasesACTRN12612000055808niversity of Auckland144
Active, not recruiting
Not Applicable
Is potent topical corticosteroid ointment covered by a plastic film dressing more effective than using potent corticosteroid ointment alone in children with atopic dermatitis?EUCTR2005-003806-27-GBPrincess Alexandra Hospital
Active, not recruiting
Phase 4
Effectiveness of corticosteroids in controlling complications after bichectomy surgeryISRCTN15802039Austral University of Chile50
Recruiting
Phase 2
corticosteroids in chronic subdural hematomachronic SubDural hematoma.Nontraumatic chronic subdural hemorrhageI62.03IRCT20200911048685N1Ahvaz University of Medical Sciences30
Active, not recruiting
Phase 1
Effectiveness of corticosteroid injection in treatment of trigger fingers: a double blinded randomized clinical trialTrigger finger (stenosing tenosynovitis) is one of the most common conditions seen by hand surgeons,Although not a severe disease, trigger fingers give disabling complaints in performance of work and ADL activities. The triggering is caused by a size mismatch between the first annular pulley (A1) and the corresponding flexor tendon sheath, but the precise etiology still remains unclear.2-4 Most often, trigger fingers do not resolve spontaneously and need some kind of treatment.Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2020-002285-14-NLJEROEN BOSCH HOSPITA300